Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
27 Jan, 2022 | 10:03h | UTC
Commentary on Twitter
Investigators assessed the in vitro activities of seven monoclonal antibodies & three antiviral drugs against #COVID19 variants. All antibodies showed no or weak neutralizing activity against omicron; two drugs effective at omicron neutralization. https://t.co/rOZzmtsDZS pic.twitter.com/shfKDW6r5q
— NEJM (@NEJM) January 26, 2022